Revenio Group Oyj (0KFH.L)
EUR 24.0
(1.48%)
EUR 24.0
(1.48%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 18.8 Million EUR | -53.1% |
| 2022 | 40.08 Million EUR | 21.39% |
| 2021 | 33.02 Million EUR | 30.85% |
| 2020 | 25.23 Million EUR | 9.77% |
| 2019 | 22.99 Million EUR | 82.18% |
| 2018 | 12.62 Million EUR | 7.29% |
| 2017 | 11.76 Million EUR | 22.83% |
| 2016 | 9.57 Million EUR | 4.23% |
| 2015 | 9.18 Million EUR | 41.56% |
| 2014 | 6.49 Million EUR | -52.35% |
| 2013 | 13.61 Million EUR | 0.27% |
| 2012 | 13.58 Million EUR | -17.69% |
| 2011 | 16.5 Million EUR | -10.79% |
| 2010 | 18.49 Million EUR | -19.51% |
| 2009 | 22.98 Million EUR | -17.98% |
| 2008 | 28.02 Million EUR | 0.0% |
| 2005 | 1.6 Million EUR | -83.94% |
| 2004 | 9.96 Million EUR | -56.9% |
| 2003 | 23.12 Million EUR | -28.13% |
| 2002 | 32.17 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 11.5 Million EUR | 121.15% |
| 2024 Q3 | 4.6 Million EUR | -13.21% |
| 2024 Q2 | 5.3 Million EUR | -53.91% |
| 2023 Q2 | 11.1 Million EUR | 8.82% |
| 2023 Q1 | 10.2 Million EUR | -4.57% |
| 2023 FY | 18.8 Million EUR | -53.1% |
| 2023 Q4 | 5.2 Million EUR | -45.26% |
| 2023 Q3 | 9.5 Million EUR | -14.41% |
| 2022 Q1 | 9.1 Million EUR | 0.83% |
| 2022 FY | 40.08 Million EUR | 21.39% |
| 2022 Q4 | 10.68 Million EUR | 5.82% |
| 2022 Q3 | 10.1 Million EUR | -2.88% |
| 2022 Q2 | 10.4 Million EUR | 14.29% |
| 2021 Q1 | 7.5 Million EUR | 48.87% |
| 2021 FY | 33.02 Million EUR | 30.85% |
| 2021 Q4 | 9.02 Million EUR | 12.81% |
| 2021 Q3 | 8 Million EUR | -6.98% |
| 2021 Q2 | 8.6 Million EUR | 14.67% |
| 2020 FY | 25.23 Million EUR | 9.77% |
| 2020 Q2 | 6.4 Million EUR | 4.92% |
| 2020 Q3 | 7.8 Million EUR | 21.88% |
| 2020 Q1 | 6.1 Million EUR | -4.55% |
| 2020 Q4 | 5.03 Million EUR | -35.41% |
| 2019 FY | 22.99 Million EUR | 82.18% |
| 2019 Q1 | 3.9 Million EUR | 14.04% |
| 2019 Q4 | 6.39 Million EUR | 3.08% |
| 2019 Q3 | 6.2 Million EUR | -7.46% |
| 2019 Q2 | 6.7 Million EUR | 71.79% |
| 2018 Q1 | 3.1 Million EUR | -21.76% |
| 2018 Q4 | 3.42 Million EUR | 14.0% |
| 2018 FY | 12.62 Million EUR | 7.29% |
| 2018 Q2 | 3.2 Million EUR | 3.23% |
| 2018 Q3 | 3 Million EUR | -6.25% |
| 2017 Q1 | 2.8 Million EUR | 13.09% |
| 2017 FY | 11.76 Million EUR | 22.83% |
| 2017 Q3 | 2.2 Million EUR | -18.52% |
| 2017 Q4 | 3.96 Million EUR | 80.09% |
| 2017 Q2 | 2.7 Million EUR | -3.57% |
| 2016 FY | 9.57 Million EUR | 4.23% |
| 2016 Q4 | 2.47 Million EUR | 12.55% |
| 2016 Q2 | 2.4 Million EUR | -7.69% |
| 2016 Q3 | 2.2 Million EUR | -8.33% |
| 2016 Q1 | 2.6 Million EUR | -15.78% |
| 2015 Q1 | 2 Million EUR | 381.69% |
| 2015 FY | 9.18 Million EUR | 41.56% |
| 2015 Q4 | 3.08 Million EUR | 71.5% |
| 2015 Q3 | 1.8 Million EUR | -14.29% |
| 2015 Q2 | 2.1 Million EUR | 5.0% |
| 2014 Q2 | 3.6 Million EUR | 2.86% |
| 2014 Q1 | 3.5 Million EUR | 5.45% |
| 2014 FY | 6.49 Million EUR | -52.35% |
| 2014 Q4 | -710 Thousand EUR | -130.87% |
| 2014 Q3 | 2.3 Million EUR | -36.11% |
| 2013 Q4 | 3.31 Million EUR | 3.72% |
| 2013 Q3 | 3.2 Million EUR | -8.57% |
| 2013 Q1 | 3.9 Million EUR | 471.85% |
| 2013 Q2 | 3.5 Million EUR | -10.26% |
| 2013 FY | 13.61 Million EUR | 0.27% |
| 2012 FY | 13.58 Million EUR | -17.69% |
| 2012 Q1 | 4.8 Million EUR | 2.11% |
| 2012 Q3 | 3.4 Million EUR | -26.09% |
| 2012 Q2 | 4.6 Million EUR | -4.17% |
| 2012 Q4 | 682 Thousand EUR | -79.94% |
| 2011 Q3 | 3.7 Million EUR | -7.5% |
| 2011 Q4 | 4.7 Million EUR | 27.05% |
| 2011 FY | 16.5 Million EUR | -10.79% |
| 2011 Q1 | 4.7 Million EUR | -4.02% |
| 2011 Q2 | 4 Million EUR | -14.89% |
| 2010 Q3 | 3.5 Million EUR | -30.0% |
| 2010 Q1 | 5.2 Million EUR | 0.37% |
| 2010 FY | 18.49 Million EUR | -19.51% |
| 2010 Q2 | 5 Million EUR | -3.85% |
| 2010 Q4 | 4.89 Million EUR | 39.91% |
| 2009 Q1 | 7 Million EUR | 0.0% |
| 2009 Q4 | 5.18 Million EUR | 5.73% |
| 2009 FY | 22.98 Million EUR | -17.98% |
| 2009 Q3 | 4.9 Million EUR | -19.67% |
| 2009 Q2 | 6.1 Million EUR | -12.86% |
| 2008 FY | 28.02 Million EUR | 0.0% |
| 2005 FY | 1.6 Million EUR | -83.94% |
| 2004 FY | 9.96 Million EUR | -56.9% |
| 2003 FY | 23.12 Million EUR | -28.13% |
| 2002 FY | 32.17 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cegedim SA | 235.64 Million EUR | 92.022% |
| Guerbet SA | 550.79 Million EUR | 96.587% |
| Nexus AG | 44.98 Million EUR | 58.208% |
| Bastide Le Confort Médical SA | 1.91 Million EUR | -882.236% |
| Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 98.541% |
| Sartorius Aktiengesellschaft | 1.02 Billion EUR | 98.161% |
| LNA Santé SA | 178.1 Million EUR | 89.445% |
| Siemens Healthineers AG | 5.59 Billion EUR | 99.664% |
| Medios AG | 23.03 Million EUR | 18.385% |
| Equasens Société anonyme | 14.67 Million EUR | -28.153% |
| Stratec SE | 41.95 Million EUR | 55.192% |